146 related articles for article (PubMed ID: 36260282)
1. Reduction of SARS-CoV-2 viral load in exhaled air by antiseptic chewing gum: a pilot trial.
Pfab F; Buelow-Johansen B; Alber D; Kriner M; Kornmann O; Stuermer M
Infection; 2023 Aug; 51(4):881-885. PubMed ID: 36260282
[TBL] [Abstract][Full Text] [Related]
2. Debulking different Corona (SARS-CoV-2 delta, omicron, OC43) and Influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and transmission.
Daniell H; Nair SK; Guan H; Guo Y; Kulchar RJ; Torres MDT; Shahed-Al-Mahmud M; Wakade G; Liu YM; Marques AD; Graham-Wooten J; Zhou W; Wang P; Molugu SK; de Araujo WR; de la Fuente-Nunez C; Ma C; Short WR; Tebas P; Margulies KB; Bushman FD; Mante FK; Ricciardi RP; Collman RG; Wolff MS
Biomaterials; 2022 Sep; 288():121671. PubMed ID: 35953331
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial.
Sevinç Gül SN; Dilsiz A; Sağlık İ; Aydın NN
Dent Med Probl; 2022; 59(3):357-363. PubMed ID: 35904769
[TBL] [Abstract][Full Text] [Related]
4. Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial.
Meister TL; Gottsauner JM; Schmidt B; Heinen N; Todt D; Audebert F; Buder F; Lang H; Gessner A; Steinmann E; Vielsmeier V; Pfaender S; Cieplik F
Virus Res; 2022 Jul; 316():198791. PubMed ID: 35504446
[TBL] [Abstract][Full Text] [Related]
5. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
6. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2.
Ferrer MD; Barrueco ÁS; Martinez-Beneyto Y; Mateos-Moreno MV; Ausina-Márquez V; García-Vázquez E; Puche-Torres M; Giner MJF; González AC; Coello JMS; Rueda IA; Aubá JMV; Español CC; Velasco AL; Abad DS; García-Esteban S; Artacho A; López-Labrador X; Mira A
Sci Rep; 2021 Dec; 11(1):24392. PubMed ID: 34937855
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal Wash with Normal Saline Decreases SARS-CoV-2 Viral Load: A Randomized Pilot Controlled Trial.
Pantazopoulos I; Chalkias A; Mavrovounis G; Dimeas I; Sinis S; Miziou A; Rouka E; Poulas K; Gourgoulianis K
Can Respir J; 2022; 2022():8794127. PubMed ID: 36247079
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study.
Perussolo J; Teh MT; Gkranias N; Tiberi S; Petrie A; Cutino-Moguel MT; Donos N
Sci Rep; 2023 Aug; 13(1):12647. PubMed ID: 37542087
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Hexetidine, Thymol and Hydrogen Peroxide-Containing Oral Antiseptics in Reducing Sars-Cov-2 Virus in the Oral Cavity: A Pilot Study.
Ogun SA; Erinoso O; Aina OO; Ojo OI; Adejumo O; Adeniran A; Bowale A; Olaniyi CA; Adedoyin BM; Mutiu B; Saka B; Oshinaike O; Arabambi W; Adejumo F; Shuaib O; Salmon AO; Abdur-Razzaq H; Njokanma OF; Ojini O; Ogboye O; Lajide O; Wright KO; Osibogun A; Abayomi A
West Afr J Med; 2022 Jan; 39(1):83-89. PubMed ID: 35167198
[TBL] [Abstract][Full Text] [Related]
11. Is the oral cavity relevant in SARS-CoV-2 pandemic?
Herrera D; Serrano J; Roldán S; Sanz M
Clin Oral Investig; 2020 Aug; 24(8):2925-2930. PubMed ID: 32577830
[TBL] [Abstract][Full Text] [Related]
12. A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2.
Gottsauner MJ; Michaelides I; Schmidt B; Scholz KJ; Buchalla W; Widbiller M; Hitzenbichler F; Ettl T; Reichert TE; Bohr C; Vielsmeier V; Cieplik F
Clin Oral Investig; 2020 Oct; 24(10):3707-3713. PubMed ID: 32876748
[TBL] [Abstract][Full Text] [Related]
13. Hypochlorous acid as an antiseptic in the care of patients with suspected COVID-19 infection.
Gessa Sorroche M; Relimpio López I; García-Delpech S; Benítez Del Castillo JM
Arch Soc Esp Oftalmol (Engl Ed); 2022 Feb; 97(2):77-80. PubMed ID: 35152952
[TBL] [Abstract][Full Text] [Related]
14. Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial.
Costa DD; Brites C; Vaz SN; de Santana DS; Dos Santos JN; Cury PR
Oral Dis; 2022 Nov; 28 Suppl 2():2500-2508. PubMed ID: 34837305
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study.
Fantozzi PJ; Pampena E; Pierangeli A; Oliveto G; Sorrentino L; Di Vanna D; Pampena R; Lazzaro A; Gentilini E; Mastroianni CM; D'Ettorre G; Polimeni A; Romeo U; Villa A
Am J Otolaryngol; 2022; 43(6):103549. PubMed ID: 35988522
[TBL] [Abstract][Full Text] [Related]
17. Short-term germ-killing effect of sugar-sweetened cinnamon chewing gum on salivary anaerobes associated with halitosis.
Zhu M; Carvalho R; Scher A; Wu CD
J Clin Dent; 2011; 22(1):23-6. PubMed ID: 21290983
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F
J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423
[TBL] [Abstract][Full Text] [Related]
19. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing.
Coleman KK; Tay DJW; Tan KS; Ong SWX; Than TS; Koh MH; Chin YQ; Nasir H; Mak TM; Chu JJH; Milton DK; Chow VTK; Tambyah PA; Chen M; Tham KW
Clin Infect Dis; 2022 May; 74(10):1722-1728. PubMed ID: 34358292
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19.
Malik M; Kunze AC; Bahmer T; Herget-Rosenthal S; Kunze T
Int J Infect Dis; 2021 Sep; 110():105-110. PubMed ID: 34242768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
